For instance, overexpression of FOXP3 is associated with worse prognosis in NSCLC, colorectal cancer, and cervical cancer but good prognosis in breast cancer, prostate cancer, and gastric cancer [85]. Here, FOXP3 is linked to breast carcinoma.